semaglutide cancer cases GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for breast patients who are obese or have type 2 diabetes, according to new research. The study Comparative safety and side effects

Policy and legislative efforts to address the threat FDA GLP-1 compounding guidance: In April, the FDA reiterated that state-licensed 503A pharmacies may only compound for individual needs without copying commercial drugs and that federally-registered 503B outsourcing facilities are limited to bulk compounding substances on the 503B bulks or drug shortage lists

provider letters?) 6

In nonobese subjects without T2DM, GLP-1 and GIP contribute nearly equally to the incretin effect, stimulating the majority of postprandial insulin release (67)

They need discernment

WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)

otherwise, they may not get the correct amount of insulin, which may affect their blood glucose levels